PAVmed Historical Income Statement
| PAVM Stock | USD 1.11 0.14 14.43% |
Historical analysis of PAVmed income statement accounts such as Other Operating Expenses of 74.8 M, Research Development of 9.5 M, Cost Of Revenue of 6.7 M or Non Recurring of 210.6 K can show how well PAVmed Inc performed in making a profits. Evaluating PAVmed income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of PAVmed's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining PAVmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PAVmed Inc is a good buy for the upcoming year.
PAVmed |
About PAVmed Income Statement Analysis
PAVmed Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to PAVmed shareholders. The income statement also shows PAVmed investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
PAVmed Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of PAVmed Inc. It is also known as PAVmed overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from PAVmed's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into PAVmed Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, PAVmed's Minority Interest is very stable compared to the past year. As of the 3rd of December 2024, Reconciled Depreciation is likely to grow to about 3.1 M, though Gross Profit is likely to grow to (3.8 M).
| 2023 | 2024 (projected) | Total Operating Expenses | 64.8M | 68.1M | Non Recurring | 236.9K | 210.6K |
PAVmed income statement Correlations
Click cells to compare fundamentals
PAVmed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PAVmed income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 14.2K | 23K | 226K | 2.6M | 2.9M | 3.1M | |
| Interest Expense | 32.7K | 53K | 5.8M | 1.3M | 589K | 559.6K | |
| Selling General Administrative | 7.7M | 12.4M | 25.6M | 41.0M | 30.9M | 32.5M | |
| Gross Profit | (14.2K) | (23K) | (85K) | (3.2M) | (4.0M) | (3.8M) | |
| Other Operating Expenses | 14.3M | 23.4M | 54.9M | 91.3M | 71.2M | 74.8M | |
| Operating Income | (14.3M) | (23.4M) | (54.4M) | (90.9M) | (68.8M) | (65.4M) | |
| Net Income From Continuing Ops | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (86.4M) | (82.1M) | |
| Ebit | (15.4M) | (35.8M) | (56.1M) | (102.0M) | (78.7M) | (74.7M) | |
| Research Development | 6.6M | 11.0M | 19.8M | 25.5M | 14.3M | 9.5M | |
| Ebitda | (15.4M) | (35.8M) | (55.9M) | (99.4M) | (75.7M) | (72.0M) | |
| Cost Of Revenue | 14.2K | 23K | 585K | 3.6M | 6.4M | 6.7M | |
| Total Operating Expenses | 14.3M | 23.4M | 54.3M | 87.7M | 64.8M | 68.1M | |
| Income Before Tax | (17.3M) | (35.9M) | (56.1M) | (103.2M) | (79.3M) | (75.3M) | |
| Total Other Income Expense Net | (3.0M) | (12.5M) | (1.7M) | (12.2M) | (10.5M) | (9.9M) | |
| Net Income Applicable To Common Shares | (16.7M) | (34.6M) | (50.6M) | (89.3M) | (80.3M) | (76.3M) | |
| Net Income | (15.9M) | (34.3M) | (50.3M) | (101.3M) | (64.2M) | (61.0M) | |
| Income Tax Expense | (1.3M) | (1.6M) | (5.8M) | (1.9M) | (13.0B) | (12.3B) | |
| Minority Interest | (814K) | (2.4M) | 5.8M | 14.3M | 15.8M | 16.6M | |
| Net Interest Income | (582.9K) | (713K) | (523K) | (1.3M) | (448K) | (470.4K) | |
| Reconciled Depreciation | 14.2K | 23K | 226K | 2.5M | 2.9M | 3.1M | |
| Non Operating Income Net Other | (7.6M) | (3.0M) | (12.5M) | (1.7M) | (1.6M) | (1.6M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.